Blazena Kaderabkova's Discussions (32)

Discussions Replied To (28) Replies Latest Activity

"Hi Trinh, we were last week in our hospital in Motol Prague and there is expected th…"

Blazena Kaderabkova replied Aug 26, 2013 to Ataluren - phase III

8 Sep 10, 2014
Reply by Trinh Nguyen

"Hi Michael, how long is your son on low dose ataluren?   "

Blazena Kaderabkova replied Feb 20, 2013 to Ataluren Webinar

45 Feb 17, 2014
Reply by Peter

"I was also surrprised with 31,3m. So the primary endpoint of the study was achieved…"

Blazena Kaderabkova replied Jan 29, 2013 to Ataluren Webinar

45 Feb 17, 2014
Reply by Peter

"Yesterday were presented top line data from PTC. Ataluren in CF - success! http://pt…"

Blazena Kaderabkova replied Jun 9, 2012 to ATALUREN - confused about the information given from PTC Therapeutics and Genzyme

51 Jun 12, 2012
Reply by Tamara Walters

"Dear Pat, There was said a lot of information, thank you very much. But I didnt unde…"

Blazena Kaderabkova replied Jun 7, 2012 to ATALUREN - confused about the information given from PTC Therapeutics and Genzyme

51 Jun 12, 2012
Reply by Tamara Walters

"This news is also presented on www.distrofiamuscular.net/news.htm  "

Blazena Kaderabkova replied Jun 2, 2012 to ATALUREN - confused about the information given from PTC Therapeutics and Genzyme

51 Jun 12, 2012
Reply by Tamara Walters

"Hello, you need to go to the orthopaedist and use insoles, both at home and when you…"

Blazena Kaderabkova replied May 9, 2012 to Walking change

29 May 14, 2012
Reply by wainaina muiruri

"I would like to ask you if any other studies of gentamicin will continue. Many thank…"

Blazena Kaderabkova replied Mar 23, 2012 to Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop Codons

5 Mar 28, 2012
Reply by Peter

"I only hope that it will affect the approval Ataluren. "

Blazena Kaderabkova replied Feb 6, 2012 to One year on Phase 2 of GSX/Prosensa Trial

54 Feb 17, 2012
Reply by Ofelia Marin

"Hallo Amrit,   thank you for this information I havent heard still about HT100. Its…"

Blazena Kaderabkova replied Jan 5, 2012 to Halo Therapeutics' HT-100 Receives FDA's Orphan Designation for Duchenne Muscular Dystrophy

6 Jan 16, 2012
Reply by Debbie Bowman

RSS

Need help using this community site? Visit Ning's Help Page.

Members

Events

© 2019   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service